10LBA Randomized phase 3 study of panitumumab with FOLFOX4 compared to FOLFOX4 alone as 1st-line treatment (tx) for metastatic colorectal cancer (mCRC): the PRIME trial
Cited by 88
Abstract
Related Papers
No related papers found
Powered by citation graph analysis